Hill A - Search Results

1

Higher risks of mother-to-child HIV transmission in countries with lower HIV prevalence: UNAIDS 2013 results for 32 countries with generalised epidemics.

Hill A, Dauncey T, Levi J, Heath K, Pérez Casas C. Hill A, et al. J Virus Erad. 2015 Oct 1;1(4):257-63. doi: 10.1016/S2055-6640(20)30927-4. J Virus Erad. 2015. PMID: 27482423 Free PMC article.

2

Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response.

Simmons B, Saleem J, Heath K, Cooke GS, Hill A. Simmons B, et al. Among authors: hill a. Clin Infect Dis. 2015 Sep 1;61(5):730-40. doi: 10.1093/cid/civ396. Epub 2015 May 17. Clin Infect Dis. 2015. PMID: 25987643 Free PMC article. Review.

3

Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries.

Hill A, Gotham D, Cooke G, Bhagani S, Andrieux-Meyer I, Cohn J, Fortunak J. Hill A, et al. J Virus Erad. 2015 Apr 1;1(2):103-10. doi: 10.1016/S2055-6640(20)30484-2. J Virus Erad. 2015. PMID: 27482399 Free PMC article.

4

InterPrEP. Internet-based pre-exposure prophylaxis with generic tenofovir DF/emtricitabine in London: an analysis of outcomes in 641 patients.

Aloysius I, Savage A, Zdravkov J, Korologou-Linden R, Hill A, Smith R, Houghton-Price V, Boffito M, Nwokolo N. Aloysius I, et al. Among authors: hill a. J Virus Erad. 2017 Oct 1;3(4):218-222. doi: 10.1016/S2055-6640(20)30317-4. J Virus Erad. 2017. PMID: 29057086 Free PMC article.

5

Safety and pharmacokinetics of dolutegravir in HIV-positive pregnant women: a systematic review.

Hill A, Clayden P, Thorne C, Christie R, Zash R. Hill A, et al. J Virus Erad. 2018 Apr 1;4(2):66-71. doi: 10.1016/S2055-6640(20)30247-8. J Virus Erad. 2018. PMID: 29682297 Free PMC article.

6

Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?

Hill A, Hughes SL, Gotham D, Pozniak AL. Hill A, et al. J Virus Erad. 2018 Apr 1;4(2):72-79. doi: 10.1016/S2055-6640(20)30248-X. J Virus Erad. 2018. PMID: 29682298 Free PMC article.

7

The impact of HIV prevalence, conflict, corruption, and GDP/capita on treatment cascades: data from 137 countries.

Levi J, Pozniak A, Heath K, Hill A. Levi J, et al. Among authors: hill a. J Virus Erad. 2018 Apr 1;4(2):80-90. doi: 10.1016/S2055-6640(20)30249-1. J Virus Erad. 2018. PMID: 29682299 Free PMC article.

8

How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP.

Pilkington V, Hill A, Hughes S, Nwokolo N, Pozniak A. Pilkington V, et al. Among authors: hill a. J Virus Erad. 2018 Oct 1;4(4):215-224. doi: 10.1016/S2055-6640(20)30312-5. J Virus Erad. 2018. PMID: 30515300 Free PMC article.

9

Is pricing of dolutegravir equitable? A comparative analysis of price and country income level in 52 countries.

Sim J, Hill A. Sim J, et al. Among authors: hill a. J Virus Erad. 2018 Oct 1;4(4):230-237. doi: 10.1016/S2055-6640(20)30311-3. J Virus Erad. 2018. PMID: 30515303 Free PMC article.

10

Are new antiretroviral treatments increasing the risks of clinical obesity?

Hill A, Waters L, Pozniak A. Hill A, et al. J Virus Erad. 2019 Jan 1;5(1):41-43. doi: 10.1016/S2055-6640(20)30277-6. J Virus Erad. 2019. PMID: 30800425 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,562 results

Search Page

Filters